Shopping Cart
Your Cart is Empty
Quantity:
Subtotal
Taxes
Shipping
Total
There was an error with PayPalClick here to try again
CelebrateThank you for your business!You should be receiving an order confirmation from Paypal shortly.Exit Shopping Cart

    

SUBSCRIBE TO OUR
 NEWSLETTER!

A CONVERGENCE OF




PUBLIC HEALTH AND INDIVIDUAL RIGHTS

A GLOBAL ORGANIZATION

MISSION STATEMENT

The Chronic Illness Advocacy & Awareness Group, Inc. (CIAAG) is a national non-profit organization focused on the public, private-partnership initiatives within the healthcare sector.  The healthcare system is changing rapidly in response to societal and political pressures.  The United States has invested billions of dollars into the restructuring of the healthcare system with a large investment into public, private-partnerships to help create and implement strategies that will help solve the nation's most complex public health issues and concerns.  As the nation moves forward with new innovative treatments and technologies, we must ensure patient rights and civil liberties are preserved.

CIAAG acts as a liaison between the public, lawmakers, and other stakeholders to facilitate productive discussions and provide recommendations to address the knowledge gaps and inconsistencies within the public, private-partnerships that are influencing access to care and healthcare as a whole in America.

We consult with the public and private sector, providing both professional expertise and lived experience regarding the issues presented by the use of public, private-partnerships to develop solutions to complex societal problems that arose via the use of pragmatic trials and the biopsychosocial approach to managing population health. 

Under Construction 

OUR IMPACT​

THE LEADERS OF A NEW INDUSTRY

Through identification and recognition of the current issues surrounding the healthcare landscape with the implementation of public, private-partnerships, CIAAG has identified and is leading an entire new industry built on the need for oversight, transparency and acknowledgement that all citizens are stakeholders and therefore, require representation.  

CIAAG affected positive societal change by providing valuable insight via their participation as a subject matter expert in group meetings with the UNODC regarding the policy decisions being made at the global level and how they effect the individuals in the communities that we serve.

A global presence consisting of 29 coalition partners 

representing 8,224,066 individuals and 70,000 physicians.

Educational initiatives and events that focus on teaching the strategy that accompanies one’s approach to advocacy and the building blocks of how to approach advocacy through our #CIAAGAdvocacy Chats. These monthly chats have encouraged and increased community engagement and participant confidence; working to amplify our collective voice and increasing awareness amongst the general population.

Upon conducting meetings wtih congressional and senatorial offices we presented our research (Violation of A Nation). In response, the FDA provided a safety announcement to the medical community advising against the forced tapering of patients who use opioid pain medications for the treatment of pain/illness.

SIGN UP FOR

CIAAG's 1st ANNUAL 

PUBLIC - HEALTH POLICY ACTIVISM

TRAINING SERIES

Training Information

Sign up for CIAAG's 1st Public Health Policy Activism series.

Open enrollment has begun for January 2023.

Registration is yearly; only those who are pre-registered will be allowed to attend.

Upon successful completion of the series, each participant will receive a copy of CIAAG's exclusive guidebook.

Fill out the form to the left and click the "sign up here" button to reserve your spot.

Training Series Sign-Up Form

Click here to acknowledge attendance*
This site uses Google reCAPTCHA technology to fight spam. Your use of reCAPTCHA is subject to Google's Privacy Policy and Terms of Service.

Thank you! Your message was sent successfully.

FOCUS AREAS

SERVICES

PROFESSIONAL SERVICES

  • Consulting Services
  • Speaking Engagements
  • Media Interviews and Appearances
  • Whitepapers/Research
  • Public Health Policy Analysis 
  • Monitor and track the impact of public health policy

SUBJECT MATTER EXPERT

  • Public health policy
  • Commercial liability insurance
  • National and international drug policy
  • Enterprise Risk Management
  • Strategic planning
  • Public-Private Partnerships

COMMU​NI​TY SERVICES

  • Public health policy activism
  • Educational materials and webinars
  • Exclusive research repository
  • Mentorship and training services
  • Facilitate communication between patients and other stakeholders

SUCCESSFUL ADVOCACY EFFORTS


CIAAG participated in the creation of the UNODC Digital Road Map to

 Promote Sustainable Drug Control Public - Private Partnerships which included a number of our recommendations for oversight, transparency and accountability.


CIAAG 's Executive Director, Lauren Deluca, was 1 of 17 experts selected to particpate on the development of the first UNODC, "Digital Roadmap," outlining key recommendations for countries to consider when pursuing the use of public-private partnerships (P3's) in relation to national and international drug policy.


The UNODC's publication included a number of recommendations from CIAAG, including but not limited to:

  • The need for strong oversight of the public-private partnerships. 
  • Outlining clear goals and the monitoring of outcomes.
  • Regulating the scientific evidence used to create evidence based practices.


This is the first document of its kind providing guidance to countries across the world on best-practices surrounding the public-private partnership initiatives. 


We are incredibly proud to have used our voice while serving on this international committee to ensure policy guidance included strong protections for the civil and human liberties of all citizens in all nations. 


CIAAG Successfully Advocated for the 

FDA Announcement Against Forced Tapering

CIAAG presented their exclusive report, Violation of a Nation to 9 congressional and senatorial offices in April 2019.  Our team requested a federal announcement be issued against the practice against involuntary discontinuation from opioid analgesic medications.  CIAAG founder Lauren Deluca, stated, "There is substantial evidence of the harms of this practice at this juncture.  it would be irresponsible not to. "


As a result of this request, the FDA issued an annoucement against the practice of involuntary discontinuation from opioid analgesic medications and the misapplication of federal guidance documents. 



    Link to Announcement  ​

Click Here 

to Read

CIAAG EXCLUSIVE REPORTS

PUBLIC, PRIVATE - PARTNERSHIPS

ETHICAL GUIDANCE & RECOMMENDATIONS

READ IT HERE

ANALYSIS OF 2022 CDC OPIOID

PRESCRIBING GUIDELINES

READ IT HERE


VIOLATION OF A NATION

READ IT HERE


A CRISIS EXPLOITED

READ IT HERE

ACTIVITIES